AG

Active Director Director DIN 08611401
DIN 08611401 First appointment Nov 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Ama Ghosh

Data last updated:

Ama Ghosh is a Director at Fewsteps Pharmaceuticals Private Limited (since 2019). The company operates in Healthcare. Fewsteps Pharmaceuticals Private Limited reported revenue of ₹9.6 Lakh (FY 2025).

DIN 08611401
Primary Designation Director
Industry Healthcare
First Appointment 15 Nov 2019
Oldest Company Age 7 yrs
Largest company Fewsteps Pharmaceuticals Private Limited · ₹9.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Nov 20192019₹9.6 Lakh (FY 2025)Active

Board colleagues of Ama Ghosh

NameDINCompanyDesignation
Mita Ghosh08611402Fewsteps Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fewsteps Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ama Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ama Ghosh

Ama Ghosh currently holds 1 directorship: Fewsteps Pharmaceuticals Private Limited (Director, since 15 Nov 2019, revenue ₹9.6 Lakh (FY 2025)).

Ama Ghosh was first appointed on 15 Nov 2019 as Director at Fewsteps Pharmaceuticals Private Limited.

The current boards of Ama Ghosh's companies include Mita Ghosh (Fewsteps Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available